T. Rowe Price Associates’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.38M | Buy |
|
|||||
|
2025
Q2 | $1.39M | Buy |
|
|||||
|
2025
Q1 | $1.11M | Buy |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $1.13M | Buy |
|
|||||
|
2024
Q2 | $980K | Buy |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $1.75M | Buy |
|
|||||
|
2023
Q3 | $1.34M | Buy |
|
|||||
|
2023
Q2 | $1.71M | Sell |
|
|||||
|
2023
Q1 | $5.71M | Sell |
|
|||||
|
2022
Q4 | $7.75M | Sell |
|
|||||
|
2022
Q3 | $8.95M | Buy |
|
|||||
|
2022
Q2 | $10.5M | Sell |
|
|||||
|
2022
Q1 | $27.4M | Buy |
|
|||||
|
2021
Q4 | $33.2M | Buy |
|
|||||
|
2021
Q3 | $42.6M | Sell |
|
|||||
|
2021
Q2 | $82.7M | Sell |
|
|||||
|
2021
Q1 | $105M | Sell |
|
|||||
|
2020
Q4 | $165M | Buy |
|
|||||
|
2020
Q3 | $115M | Sell |
|
|||||
|
2020
Q2 | $207M | Sell |
|
|||||
|
2020
Q1 | $173M | Buy |
|
|||||
|
2019
Q4 | $48.4M | Sell |
|
|||||
|
2019
Q3 | $65.7M | Sell |
|
|||||
|
2019
Q2 | $72.3M | Sell |
|
|||||
|
2019
Q1 | $88.6M | Sell |
|
|||||
|
2018
Q4 | $84.8M | Sell |
|
|||||
|
2018
Q3 | $176M | Buy |
|
|||||
|
2018
Q2 | $107M | Buy |
|
|||||
|
2018
Q1 | $48.2M | Sell |
|
|||||
|
2017
Q4 | $69.2M | Buy |
|
|||||
|
2017
Q3 | $61.4M | Buy |
|
|||||
|
2017
Q2 | $11.2M | Buy |
|
|||||
|
2017
Q1 | $5.2M | Sell |
|
|||||
|
2016
Q4 | $5.2M | Sell |
|
|||||
|
2016
Q3 | $6.78M | Buy |
|
|||||
|
2016
Q2 | $3.34M | Sell |
|
|||||
|
2016
Q1 | $4.98M | Buy |
|
|||||
|
2015
Q4 | $3.89M | Sell |
|
|||||
|
2015
Q3 | $5.14M | Buy |
|